![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PCNX4 |
Gene summary for PCNX4 |
![]() |
Gene information | Species | Human | Gene symbol | PCNX4 | Gene ID | 64430 |
Gene name | pecanex 4 | |
Gene Alias | C14orf135 | |
Cytomap | 14q23.1 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q63HM2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
64430 | PCNX4 | RNA-P17T-P17T-2 | Human | Lung | IAC | 4.30e-05 | 5.08e-01 | 0.3371 |
64430 | PCNX4 | RNA-P17T-P17T-4 | Human | Lung | IAC | 7.92e-03 | 3.25e-01 | 0.343 |
64430 | PCNX4 | RNA-P17T-P17T-8 | Human | Lung | IAC | 1.46e-09 | 6.06e-01 | 0.3329 |
64430 | PCNX4 | RNA-P6T1-P6T1-4 | Human | Lung | MIAC | 3.26e-05 | 7.70e-01 | -0.0263 |
64430 | PCNX4 | RNA-P6T2-P6T2-1 | Human | Lung | IAC | 1.99e-06 | 2.76e-01 | -0.0166 |
64430 | PCNX4 | RNA-P6T2-P6T2-2 | Human | Lung | IAC | 3.12e-08 | 3.17e-01 | -0.0132 |
64430 | PCNX4 | RNA-P6T2-P6T2-3 | Human | Lung | IAC | 1.97e-09 | 3.15e-01 | -0.013 |
64430 | PCNX4 | RNA-P6T2-P6T2-4 | Human | Lung | IAC | 2.00e-02 | 2.34e-01 | -0.0121 |
64430 | PCNX4 | RNA-P7T1-P7T1-4 | Human | Lung | AIS | 1.78e-02 | 3.66e-01 | -0.0809 |
64430 | PCNX4 | HTA12-15-2 | Human | Pancreas | PDAC | 7.26e-07 | 6.06e-01 | 0.2315 |
64430 | PCNX4 | HTA12-23-1 | Human | Pancreas | PDAC | 2.07e-02 | 5.65e-01 | 0.3405 |
64430 | PCNX4 | HTA12-26-1 | Human | Pancreas | PDAC | 9.38e-10 | 6.57e-01 | 0.3728 |
64430 | PCNX4 | HTA12-29-1 | Human | Pancreas | PDAC | 4.10e-25 | 6.74e-01 | 0.3722 |
64430 | PCNX4 | male-WTA | Human | Thyroid | PTC | 1.41e-16 | 1.22e-01 | 0.1037 |
64430 | PCNX4 | PTC01 | Human | Thyroid | PTC | 2.67e-08 | 1.11e-01 | 0.1899 |
64430 | PCNX4 | PTC04 | Human | Thyroid | PTC | 3.24e-13 | 2.79e-01 | 0.1927 |
64430 | PCNX4 | PTC05 | Human | Thyroid | PTC | 2.01e-10 | 3.59e-01 | 0.2065 |
64430 | PCNX4 | PTC06 | Human | Thyroid | PTC | 1.72e-13 | 4.01e-01 | 0.2057 |
64430 | PCNX4 | PTC07 | Human | Thyroid | PTC | 3.21e-16 | 3.79e-01 | 0.2044 |
64430 | PCNX4 | ATC09 | Human | Thyroid | ATC | 8.87e-17 | 4.13e-01 | 0.2871 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PCNX4 | SNV | Missense_Mutation | novel | c.1926G>A | p.Met642Ile | p.M642I | Q63HM2 | protein_coding | tolerated(0.39) | benign(0.052) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
PCNX4 | SNV | Missense_Mutation | c.139N>A | p.Leu47Ile | p.L47I | Q63HM2 | protein_coding | tolerated(0.09) | probably_damaging(0.994) | TCGA-A5-A0GP-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
PCNX4 | SNV | Missense_Mutation | novel | c.2633C>T | p.Ala878Val | p.A878V | Q63HM2 | protein_coding | tolerated(0.26) | benign(0.003) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PCNX4 | SNV | Missense_Mutation | rs773790296 | c.3446C>T | p.Thr1149Met | p.T1149M | Q63HM2 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PCNX4 | SNV | Missense_Mutation | rs367695868 | c.2792C>T | p.Ser931Leu | p.S931L | Q63HM2 | protein_coding | tolerated(0.33) | benign(0) | TCGA-AP-A056-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PCNX4 | SNV | Missense_Mutation | c.1856N>A | p.Cys619Tyr | p.C619Y | Q63HM2 | protein_coding | deleterious(0.01) | possibly_damaging(0.626) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
PCNX4 | SNV | Missense_Mutation | c.796N>T | p.Ala266Ser | p.A266S | Q63HM2 | protein_coding | deleterious(0.02) | probably_damaging(0.996) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
PCNX4 | SNV | Missense_Mutation | novel | c.274N>G | p.Leu92Val | p.L92V | Q63HM2 | protein_coding | tolerated(0.12) | benign(0.001) | TCGA-AP-A1E0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | SD |
PCNX4 | SNV | Missense_Mutation | rs760664838 | c.2089N>T | p.Arg697Cys | p.R697C | Q63HM2 | protein_coding | deleterious(0.01) | possibly_damaging(0.61) | TCGA-AP-A1E0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | SD |
PCNX4 | SNV | Missense_Mutation | c.2654N>T | p.Ala885Val | p.A885V | Q63HM2 | protein_coding | tolerated(0.07) | benign(0.015) | TCGA-AX-A05S-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unspecific | Carboplatin & Paclitaxel | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |